Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)-Reference-Cited by-同舟云学术

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)

Published:2010-06 Issue:9 Volume:46 Page:1703-1711
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Correale Pierpaolo,Marra Monica,Remondo Cinzia,Migali Cristina,Misso Gabriella,Arcuri Felice Paolo,Del Vecchio Maria Teresa,Carducci Antonietta,Loiacono Lucia,Tassone Pierfrancesco,Abbruzzese Alberto,Tagliaferri Pierosandro,Caraglia Michele

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. The EGFR family and its ligands in human cancer: signalling mechanism and therapeutic opportunities;Yarden;Eur J Cancer,2001

2. The ErbB signaling network: receptor heterodimerization in development and cancer;Olayioye;EMBO J,2000

3. Epidermal growth factor receptor (EGFR) signaling in cancer;Normanno;Gene,2006

4. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis;Porter;Oncogene,1998

5. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics;Frontiers in Immunology;2024-08-08

2. EGFR-Targeted Antibody–Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells;Cancers;2024-03-22

3. The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review;Cancer Treatment Reviews;2024-03

4. China special issue on gastrointestinal tumors‐Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with RAS wild‐type metastatic colorectal cancer: Cohort B of the phase II CRACK study;International Journal of Cancer;2023-05-10

5. Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure;Current Cancer Drug Targets;2021-10-20